Vaginal prostaglandins for the ripe cervix

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Clinical Pharmacology

Background:

• Induction of labor is a common obstetric procedure.
• Cervical ripeness, assessed by Bishop Score, influences labor induction methods.
• Prostaglandin E2 (PGE2) is a key hormone in cervical ripening and labor initiation.

Purpose of the Study:

• To evaluate the efficacy of vaginal prostaglandin (PGE2) tablets for labor induction in women with a favorable cervix (Bishop Score ≥ 5).
• To compare PGE2 tablet induction with artificial rupture of membranes alone.

Main Methods:

• A randomized controlled trial involving 209 women with a Bishop Score ≥ 5.
• Participants were randomized to receive either PGE2 tablets (n=106) or artificial rupture of membranes only (n=103).
• Key outcomes measured included labor duration, oxytocin and analgesia use, delivery mode, and complications.

Main Results:

• The first stage of labor was significantly shorter in parous women receiving PGE2 (194 min vs. 319 min).
• The interval from induction to delivery was reduced in primigravidas using PGE2.
• Reduced rates of oxytocin augmentation (75% vs. 100% in primiparas, 40% vs. 80% in multiparas), epidural analgesia, and instrumental delivery were observed in the PGE2 group.

Conclusions:

• Vaginal PGE2 tablets are effective for labor induction in women with a ripe cervix.
• PGE2 use is associated with a shorter first stage of labor.
• This method leads to decreased requirements for oxytocin, analgesia, and instrumental interventions.